NEW YORK--Cancer of the thyroid, a highly treatable disease, is often overlooked in its earliest stages and, once diagnosed, may be treated too aggressively. In an effort to address these issues and to standardize treatment, the American Association of Clinical Endocrinologists (AACE) has published new guidelines for the management of thyroid carcinoma.
The University of Texas M.D. Anderson Cancer Center is studying a drug that may save thyroid cancer patients time, inconvenience, and discomfort.
NEWARK, NJ--The Garden State Cancer Center has received a research grant of $605,000 from the FDA to develop a new treatment for medullary thyroid carcinoma. "The new therapy is based upon antibodies we have developed that target this cancer very selectively," said Dr. Malik Juweid, director of nuclear medicine and principal investigator on the grant.
Papillary thyroid cancer is predominantly a sporadic disease that usually presents as an asymptomatic thyroid mass in a euthyroid patient. Irradiation to the neck during childhood significantly increases the subsequent risk of
Dr. Vassilopoulou-Sellin begins her discussion advocating near total thyroidectomy with post-operation radiation iodine ablation for most patients. This is a thesis that can be questioned in terms of the numerous studies in recent years about risk
